Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1394, Issue 1, 1998, Pages 33-42

  Kern, Hartmut ^a   Volk, Thomas ^a   Knauer Schiefer, Suzanne ^a   Mieth, Tanja ^a   Rüstow, Bernd ^a   Kox, Wolfgang J ^a   Schlame, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calcium release; Inflammation; Phospholipid; Platelet aggregation; Platelet activating factor; Serotonin

Indexed keywords

APAFANT; GINKGOLIDE B; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RABBIT; SEROTONIN RELEASE; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CALCIUM; HUMANS; MONOCYTES; PHOSPHATIDYLCHOLINES; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; RABBITS; SEROTONIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031689740     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(98)00093-7     Document Type: Article

References (27)

1. Smiley P.L., Stremler K.E., Prescott S.M., Zimmermann G.A., McIntyre T.M. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266:1991;11104-11110.
2. Patel K.D., Zimmermann G.A., Prescott S.M., McIntyre T.M. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J. Biol. Chem. 267:1992;15168-15175.
3. Hanahan D.J. Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55:1986;483-509.
4. G.M. Matuschak, Multiple system organ failure: clinical expression, pathogenesis, and therapy, in: J.B. Hall, G.A. Schmidt, L.D.H. Wood (Eds.), Principles of Critical Care, McGraw-Hill, New York, 1992, pp. 613-636.
5. M. Koltai, P. Guinot, D. Hosford, P.G. Braquet, Platelet-activating factor in septic shock, in: W.C. Shoemaker, S.M. Ayres, A. Grenvik, P.R. Holbrook (Eds.), Textbook of Critical Care, Saunders, Philadelphia, PA, 1995, pp. 215-223.
6. Tanaka T., Iimori M., Tsukatani H., Tokumura A. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. Biochim. Biophys. Acta. 1210:1994;202-208.
7. Demopoulos C.A., Pinckard R.N., Hanahan D.J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254:1979;9355-9358.
8. Blank M.L., Cress E.A., Lee T.-C., Malone B., Surles J.R., Piantadosi C., Snyder F. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses. Res. Commun. Chem. Pathol. Pharmacol. 38:1982;3-20.
9. Stremler K.E., Stafforini D.M., Prescott S.M., McIntyre T.M. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J. Biol. Chem. 266:1991;11095-11103.
10. Valone F.H., Coles E., Reinhold V.R., Goetzl E.J. Specific binding of phospholipid platelet-activating factor by human platelets. J. Immunol. 129:1982;1637-1641.
11. O'Flaherty J.T., Tessner T., Greene D., Redmann J.R., Wykle R.L. Comparison of 1-O-alkyl-, 1-O-alk-1′-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. Biochim. Biophys. Acta. 1210:1994;209-216.
12. Lehr H.-A., Saetzler R.K., Jurek A., Arfors K.E., Zimmermann G.A., Prescott S.M., McIntyre T.M. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J. Clin. Invest. 99:1997;2358-2364.
13. Pryor W.A., Stone K. Oxidants in cigarette smoke. Ann. New York Acad. Sci. 686:1993;12-28.
14. Schlame M., Haupt R., Wiswedel I., Kox W.J., Rüstow B. Identification of short-chain oxidized phosphatidylcholine in human plasma. J. Lipid Res. 37:1996;2608-2615.
15. Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog. Lipid Res. 34:1995;151-184.
16. Itabe H., Kushi Y., Handa S., Inoue K. Identification of 2-azelaoylphosphatidylcholine as one of the cytotoxic products generated during oxyhemoglobin-induced peroxidation of phosphatidylcholine. Biochim. Biophys. Acta. 962:1988;8-15.
17. Tanaka T., Tokumura A., Tsukatani H. Platelet-activating factor (PAF)-like phospholipids formed during peroxidation of phosphatidylcholines from different foodstuffs. Biosci. Biotech. Biochem. 59:1995;1389-1393.
18. Goetzl E.J., Derian C.K., Tauber A.I., Valone F.H. Novel effects of 1-O-hexadecyl-2-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. Biochem. Biophys. Res. Commun. 94:1980;881-888.
19. S. Hamilton, R.J. Hamilton, P.A. Sewell, Extraction of lipids and derivate formation, in: R.J. Hamilton, S. Hamilton (Eds.), Lipid Analysis. A Practical Approach, IRL Press, Oxford, 1992, pp. 13-64.
20. Patton G.M., Cann S., Brunengraber H., Lowenstein J.M. Separation of methyl esters of fatty acids by gas chromatography on capillary columns, including the separation of deuterated from non-deuterated fatty acids. Methods Enzymol. 72:1981;8-20.
21. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234:1959;466-468.
22. Vaskovsky V.E., Kostetsky E.Y. Modified spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 9:1968;396.
23. Yue T.-L., Rabinovici R., Farhat M., Feuerstein G. Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. Prostaglandins. 39:1990;469-480.
24. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
25. 2+ changes in endothelial cells induced by low doses of reactive oxygen species: role of hydrogen peroxide. Mol. Cell. Biochem. 171:1997;11-21.
26. Watson A.D., Leitinger N., Navab M., Faull K.F., Hörkkö S., Witztum J.L., Palinski W., Schwenke D., Salomon R.G., Sha W., Subbanagounder G., Fogelman A.M., Berliner J.A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:1997;13597-13607.
27. Zimmermann G.A., Prescott S.M., McIntyre T.M. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids. J. Nutr. 125:1995;1661S-1665S.